Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Indolfi

Showing results (181-190 of 223) with videos related to

Pageof 23
Sort By:
Infectious Diseases and Therapy|March 20, 2026
Impact of Nirsevimab on Pediatric RSV-Related Lower Respiratory Tract Infections: A Retrospective Pre-Post Observational Study in Tuscany, ItalyFrancesco Nieddu, Marta Verzieri, Marina Vignoli, et al.
Frontiers in Public Health|July 18, 2025
The impact of nirsevimab prophylaxis on RSV hospitalizations: a real-world cost-benefit analysis in Tuscany, ItalyVieri Lastrucci, Martina Pacifici, Giorgia Alderotti, et al.
BMJ Public Health|February 28, 2025
Modelling the potential clinical and economic impact of universal antenatal hepatitis C (HCV) screening and providing treatment for pregnant women with HCV and their infants in Egypt: a cost-effectiveness studyNadia Hachicha-Maalej, Clotilde Lepers, Intira Jeannie Collins, et al.
Journal of Human Immunity|May 22, 2026
Expanding the scope of PI3K-δ inhibition: Leniolisib treatment in PRKCD deficiencyLorenzo Lodi, Valentina Guarnieri, Matilde Peri, et al.
JHEP Reports : Innovation in Hepatology|March 27, 2025
Real-world experience with odevixibat in children with progressive familial intrahepatic cholestasisAngelo Di Giorgio, Marco Sciveres, Maurizio Fuoti, et al.
Gastroenterology|April 29, 2008
Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver diseaseFlavia Bortolotti, Gabriella Verucchi, Calogero Cammà, et al.
The Journal of Pediatrics|November 22, 2019
Alagille Syndrome and Chronic Arthritis: An International Case SeriesGiovanna Ferrara, Teresa Giani, Scott M Lieberman, et al.
Atherosclerosis|September 8, 2017
Molecular and clinical characterization of a series of patients with childhood-onset lysosomal acid lipase deficiency. Retrospective investigations, follow-up and detection of two novel LIPA pathogenic variantsLivia Pisciotta, Giulia Tozzi, Lorena Travaglini, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 25, 2020
Management of Hepatitis B Virus Infection and Prevention of Hepatitis B Virus Reactivation in Children With Acquired Immunodeficiencies or Undergoing Immune Suppressive, Cytotoxic, or Biological Modifier TherapiesGiuseppe Indolfi, Mona Abdel-Hady, Sanjay Bansal, et al.
The Lancet. Gastroenterology & Hepatology|April 16, 2019
Hepatitis B virus infection in children and adolescentsGiuseppe Indolfi, Philippa Easterbrook, Geoffrey Dusheiko, et al.
Pageof 23

Showing results (181-190 of 223) with videos related to

Sort By:
Pageof 23
Infectious Diseases and Therapy|March 20, 2026
Impact of Nirsevimab on Pediatric RSV-Related Lower Respiratory Tract Infections: A Retrospective Pre-Post Observational Study in Tuscany, ItalyFrancesco Nieddu, Marta Verzieri, Marina Vignoli, et al.
Frontiers in Public Health|July 18, 2025
The impact of nirsevimab prophylaxis on RSV hospitalizations: a real-world cost-benefit analysis in Tuscany, ItalyVieri Lastrucci, Martina Pacifici, Giorgia Alderotti, et al.
BMJ Public Health|February 28, 2025
Modelling the potential clinical and economic impact of universal antenatal hepatitis C (HCV) screening and providing treatment for pregnant women with HCV and their infants in Egypt: a cost-effectiveness studyNadia Hachicha-Maalej, Clotilde Lepers, Intira Jeannie Collins, et al.
Journal of Human Immunity|May 22, 2026
Expanding the scope of PI3K-δ inhibition: Leniolisib treatment in PRKCD deficiencyLorenzo Lodi, Valentina Guarnieri, Matilde Peri, et al.
JHEP Reports : Innovation in Hepatology|March 27, 2025
Real-world experience with odevixibat in children with progressive familial intrahepatic cholestasisAngelo Di Giorgio, Marco Sciveres, Maurizio Fuoti, et al.
Gastroenterology|April 29, 2008
Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver diseaseFlavia Bortolotti, Gabriella Verucchi, Calogero Cammà, et al.
The Journal of Pediatrics|November 22, 2019
Alagille Syndrome and Chronic Arthritis: An International Case SeriesGiovanna Ferrara, Teresa Giani, Scott M Lieberman, et al.
Atherosclerosis|September 8, 2017
Molecular and clinical characterization of a series of patients with childhood-onset lysosomal acid lipase deficiency. Retrospective investigations, follow-up and detection of two novel LIPA pathogenic variantsLivia Pisciotta, Giulia Tozzi, Lorena Travaglini, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 25, 2020
Management of Hepatitis B Virus Infection and Prevention of Hepatitis B Virus Reactivation in Children With Acquired Immunodeficiencies or Undergoing Immune Suppressive, Cytotoxic, or Biological Modifier TherapiesGiuseppe Indolfi, Mona Abdel-Hady, Sanjay Bansal, et al.
The Lancet. Gastroenterology & Hepatology|April 16, 2019
Hepatitis B virus infection in children and adolescentsGiuseppe Indolfi, Philippa Easterbrook, Geoffrey Dusheiko, et al.
Pageof 23